Imagine a room full of your closest friends and family. The odds are that heart disease will affect at least one of them. Heart disease is the leading cause of death for both men and women in the United States, claiming a life every 33 seconds. For decades, we have been told that lowering low-density liproprotein (LDL) cholesterol—so-called bad cholesterol—is the key to heart health. But with odds like that, something isn’t adding up.
“I think the current model is oversimplified and rather myopic,” Nick Norwitz, a Harvard medical student who holds a doctorate in physiology from Oxford, told The Epoch Times. “LDL is the most common biomarker now. There are better markers.”
